Effects last 3 to 4 hours

(2015) described the development of angiotensin IV analogs including Dihexa and their HGF/c-Met potentiation mechanism (PMID: 25455861) Expression of Concern: The landmark 2012 paper describing Dihexa's cognitive effects received an expression of concern from the journal (PMID: 34551989), citing data integrity issues including questioned Western blot images Retraction: A follow-up paper from the same research group was retracted (PMID: 40312093), further undermining the evidence base for Dihexa's reported effects No Human Studies: No clinical trials, pharmacokinetic studies, or safety assessments have been conducted in humans Limited Independent Replication: The core claims about Dihexa's cognitive-enhancing effects have not been independently replicated by groups outside the original laboratory The Evidence Gap: This comparison starkly illustrates the difference between a compound with decades of clinical validation (Cerebrolysin) and one with provocative preclinical data undermined by integrity concerns (Dihexa)

We formulate our copper peptide serum at 1% GHK-Cu, the concentration studied in published research, so your results aren't being diluted by 30 other filler ingredients
Use alcohol wipes on the rubber stoppers of the peptide vial and solvent vial
Key Takeaways BPC-157 is a peptide that is taken orally or by injection
Response rates vary by study, but FDA documentation indicates approximately 39% of men experience moderate to dense hair regrowth on the crown when using 5% minoxidil consistently